Puma Biotechnology (PBYI) Inventory (2017 - 2026)

Puma Biotechnology has reported Inventory for 10 years, with the latest figure at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 0.66% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (down 0.66% YoY), and the FY2025 full-year result was $5.5 million, down 36.78% from the prior year.
• Inventory for Q1 2026 stood at $8.7 million, up from $5.5 million in the prior quarter.
• The five-year high for Inventory was $9.5 million in Q3 2025, with the low at $2.7 million in Q3 2024.
• Historically, Inventory has averaged $6.9 million across 5 years, with a median of $7.1 million in 2024.
• Annual changes were most pronounced in 2024 — Inventory sank 52.93% — and 2025, when it surged 254.51%.
• Puma Biotechnology's Inventory stood at $4.5 million in 2022, then soared by 56.43% to $7.1 million in 2023, then advanced by 23.22% to $8.7 million in 2024, then slumped by 36.78% to $5.5 million in 2025, then soared by 57.62% to $8.7 million in 2026.
• The last three Inventory figures came in at $8.7 million (Q1 2026), $5.5 million (Q4 2025), and $9.5 million (Q3 2025), per Business Quant data.